Navigation Links
Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads
Date:2/22/2009

New procedure could offer a safer, more convenient treatment for spine tumors

LAS VEGAS, Feb. 22 /PRNewswire-USNewswire/ -- For orthopaedic researcher Joyce Keyak, Ph.D., finding ways to battle breast cancer is a personal as well as a professional mission. Her cousin died from the disease several years ago. Dr. Keyak still remembers the incredible pain her cousin experienced when the cancer spread to her spine. A new study released by Dr. Keyak and her colleagues at the University of California, Irvine, shows patients whose breast cancer metastasizes to their spines may have a better option than the usual treatment, which can include up to 10 sessions of radiation therapy. The study looked at alternative -- injecting radioactive bone cement into the vertebral body -- with promising results.

The UCI researchers collaborated with a colleague from St. Jude Heritage Medical Group in Fullerton, Calif., to investigate this technique. Dr. Keyak is presenting the team's findings in the paper "Feasibility of Using Radioactive Bone Cement to Treat Vertebral Metastases" during the 55th Annual Meeting of the Orthopaedic Research Society, Feb. 22-25, 2009, in Las Vegas.

"With further development, this technology may yield a clinically feasible procedure that would eliminate the need for 10 radiation therapy sessions, making it more convenient for the patient," says Dr. Keyak, an associate professor in UCI's department of orthopaedic surgery. "This procedure would also deliver a higher dose to the bone metastases and a lower dose to the spinal cord and other normal tissues than conventional external beam radiation therapy, potentially improving the clinical outcome," she explains. "The negligible dose to the spinal cord would also make it possible to treat recurrent spinal tumors in patients who have already received the maximum allowable radiation dose to the spinal cord."

According to the A
'/>"/>

SOURCE Orthopaedic Research Society
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
2. Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers
3. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer
4. Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
5. Agendias Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
6. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
7. New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement
8. Agendias MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
9. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
10. New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
11. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...-FirstCall/--Orexigen®Therapeutics,Inc.(Nasda...atmentofobesity,todayannouncedthatonNovember18,200...ctorsgrantedaninducementstockoptiontopurchase200,0...yappointedHeadoftheGlobalContraveProgram. ,, Th...theextentpermittedbylawandhasanexercisepricepersha...
(Date:11/24/2009)...ewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),...mercializingnovelpainmanagementtherapies,todayanno...ors,effectiveNovember19,2009.Mr.Orwinisa20-yearsal...yandhasbeeninstrumentalinthelaunchofseveralimporta...iorVicePresident,BioOncologyBusinessUnitatGenentec...
(Date:11/23/2009)...--TwooftheChicagoarea,sleadingBoardCertifiedDiagno...stimaging,couplingthelatesttechnologyindigitalmamm...bilitytohavethefullrangeofdigitalimagingcompleted,...theoffice.Drs.AhmedFaragandJoanWerberaredelivering...onthwaitforanappointmentcommonlyfoundinChicago,fro...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 1Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 4Next generation software system for flood warning and risk analysis to be developed 8704 1Next generation software system for flood warning and risk analysis to be developed 8704 2Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 1Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 2Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 3Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its 24118 9 Million Ou 12433 4
...nc. (CTI) announces data presented at AACR-NCI-EOR...RANCISCO, Oct. 26 Cell Therapeutics,Inc. (CTI) (N...M), a,wholly-owned subsidiary of CTI, announced ne...ates during the 19th annual AACR-NCI-EORTC Symposi... identifying specific,tumor types with a higher li...
...ch Provides Tolerable and Effective Symptom Contro...SHPGY, TSX: SHQ), the global specialty biopharmace...h study of DAYTRANA(TM) (methylphenidate,transderm...sorder (ADHD),patch, demonstrated that DAYTRANA pr...ontrol improvement in children aged 6 to 12 years....
Other Medicine Technology:Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 2Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 3Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 4Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 5
(Date:11/24/2009)...ire/--NIP,Inc.todayannouncedtheacquisitionofRetire...cutivecompensationandbenefitplanprovidersheadquart...sAngeles,Milwaukee,Boston,ChicagoandAtlanta.RCGwas...heexecutivebenefitsindustry. ,, "Weareexcitedto...antmarketpresence,"statesBillPollock,ChairmanandFo...
(Date:11/24/2009)...ire-USNewswire/--Dr.NelsonEscobar,aphysicianwithth...heJamesBradyAward.TheawardwaspresentedtohimbytheBr...alconferenceonOctober30,2009. ,, Accordingtothe...ionofhisexpertiseinaddressingthecomplexneedsofpers...xceptionalcareofhispatientsandtheirfamiliesastheyr...
(Date:11/24/2009)...FirstCall/--CenteneCorporation(NYSE: CNC )todayann...tedCenteneasoneoftwoCoordinatedCareOrganizationsto...k(MississippiCAN),acoordinatedcareprogramforMissis...Divisiontoexecuteacontractinwhichthecompanywillser...thPlan(Magnolia). ,, BasedinJackson,Miss.,Magno...
(Date:11/24/2009)...er greatly between high- and low-volume centers, s...ay News) -- Do hospitals that conduct the most ang...r patients? Maybe not. , Prior research had sug... to artery-opening procedures, but a new study inv...lume hospitals performing more or less equally. ,...
(Date:11/24/2009)...nds no added use but higher costs , , TU...mer drug ads may contribute to higher Medicaid cos...f the widely used antiplatelet drug clopidogrel (P...5 for 27 state Medicaid programs found that direct...ncrease people,s use of the drug but appeared to b...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Advertising to Consumers May Raise Drug Prices 2
...21, 2008 A recent study shows that pre-operative a...cal therapists allow for early diagnosis and succe...cted by the National Naval Medical Center (NNMC) a...e journal, Cancer (April 25, 2008). The authors d...
..., discomfort may be driving factor, study suggests...eople with asthma may be at increased risk for sui... suicidal thoughts without suicide attempts, accor...der, from the U.S. National Comorbidity Survey Rep...
... REVERSE MENTAL ACUITY DEFICITS IN SMOKERS WHO,ARE...view to Address FAA,Ruling on Smoking Cessation Pr... Federal Aviation,Administration (FAA) that it has...this news does not include NRT, which,is deemed sa...
...subgroup of participants in the Womens Health Init...sts that healthy, postmenopausal women whose blood... increased, short-term risk for heart attack when ...) cholesterol to high-density lipoprotein (HDL, or...
...er cells from embryonic stem cells, find clues to ...y 23 (HealthDay News) -- Human liver cells have be... model, hopefully opening the door to help scienti...s that were presented this week at Digestive Disea...
...ompanies establishing online personal health recor...king robotic surgery routine, it makes sense to ha...ursing staff, care managers and other healthcare w...stem. , Akio Koyama of Yamagata University, Japan...
Other Medicine News:Health News:New study shows positive role physical therapists play in lymphedema diagnois and treatment 2Health News:Asthma Associated With Suicidal Thoughts, Attempts 2Health News:MultiVu Video Feed: FREE NICOTINE REPLACEMENT THERAPY (NRT) TO BE OFFERED TO REGISTERED PILOTS INTERESTED IN QUITTING RELIEF IN LIGHT OF RECENT FAA RULINGS 2Health News:Blood cholesterol levels predict risk of heart disease due to hormone therapy 2Health News:New Hope for Liver Diseases 2Health News:New Hope for Liver Diseases 3Health News:Remote-control health 2
...ceMate is the industry's most powerful, comprehens...vailable. In fact, OfficeMate is the most widely u...t of every three computerized eyecare businesses u... practice management needs including patient demog...
Winx Pro Practice Management Software for Eyecare Professionals
E-Z Frame Platinum
VitalWorks Intuition PM Ophthalmology
Medicine Products: